176 related articles for article (PubMed ID: 8077154)
1. Clozapine treatment in Denmark: concomitant psychotropic medication and hematologic monitoring in a system with liberal usage practices.
Peacock L; Gerlach J
J Clin Psychiatry; 1994 Feb; 55(2):44-9. PubMed ID: 8077154
[TBL] [Abstract][Full Text] [Related]
2. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients.
McKee JR; Wall T; Owensby J
Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):26-32. PubMed ID: 21459736
[TBL] [Abstract][Full Text] [Related]
3. Clozapine: the commitment to patient safety.
Alphs LD; Anand R
J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
[TBL] [Abstract][Full Text] [Related]
4. [Hematologic effects of clozapine: evaluation of the international experience].
Lamarque V
Encephale; 1995 Jun; 21 Spec No 3():59-60. PubMed ID: 7628344
[TBL] [Abstract][Full Text] [Related]
5. Clozapine treatment after agranulocytosis induced by classic neuroleptics.
Bauer M; Mackert A
J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-associated agranulocytosis: risk and aetiology.
Krupp P; Barnes P
Br J Psychiatry Suppl; 1992 May; (17):38-40. PubMed ID: 1418887
[TBL] [Abstract][Full Text] [Related]
7. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
8. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
9. Blood dyscrasias in clozapine-treated patients in Italy.
Lambertenghi Deliliers G
Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
[TBL] [Abstract][Full Text] [Related]
10. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
Alvir JM; Lieberman JA; Safferman AZ; Schwimmer JL; Schaaf JA
N Engl J Med; 1993 Jul; 329(3):162-7. PubMed ID: 8515788
[TBL] [Abstract][Full Text] [Related]
11. [Clozapine in adolescence onset schizophrenia].
Levkowitz Y; Kronnenberg Y; Kaysar N; Harari H; Gaoni B
Harefuah; 1994 Jul; 127(1-2):16-8, 63. PubMed ID: 7959380
[TBL] [Abstract][Full Text] [Related]
12. Agranulocytosis: incidence and risk factors.
Alvir JM; Lieberman JA
J Clin Psychiatry; 1994 Sep; 55 Suppl B():137-8. PubMed ID: 7961558
[TBL] [Abstract][Full Text] [Related]
13. Prescribing and monitoring clozapine in Christchurch.
McKean A; Vella-Brincat J; Begg E
Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375
[TBL] [Abstract][Full Text] [Related]
14. Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
Lamberti JS; Bellnier TJ; Schwarzkopf SB; Schneider E
J Clin Psychiatry; 1995 Jun; 56(6):256-9. PubMed ID: 7539786
[TBL] [Abstract][Full Text] [Related]
15. Haematological side effects of clozapine: patient characteristics.
Miller PR; Cutten AE
N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
[TBL] [Abstract][Full Text] [Related]
16. [Clozapine screening: white bloodcell counts no longer sufficient].
Cohen D;
Tijdschr Psychiatr; 2010; 52(11):785-90. PubMed ID: 21064021
[TBL] [Abstract][Full Text] [Related]
17. [A case study; ethnicity and clozapine, a risky combination?].
Laan WJ; Ramlal D
Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282
[TBL] [Abstract][Full Text] [Related]
18. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
19. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
20. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]